Senti Biosciences Holdings (SNTI) Total Debt (2021 - 2024)

Senti Biosciences Holdings (SNTI) recorded quarterly Total Debt of $20000.0 in Q3 2024, little changed quarter-over-quarter from $20000.0 in Q2 2024.

Senti Biosciences Holdings (SNTI) Total Debt (2021 - 2024) Analysis & Trends

Senti Biosciences Holdings' Total Debt history runs 2 years deep, the most recent figure standing at $20000.0 for Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	319.10 Mn
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	-
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Senti Biosciences Holdings	21.76 Mn	21.76 Mn	-	-

Download Data